© 1999 by European Society of Cardiology
Copyright © 1999, European Society of Cardiology
Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model
aDepartment of Physiology, University of Manitoba, Manitoba, Canada
bDepartment of Medicine, University of Manitoba, Manitoba, Canada
cInstitute of Cardiovascular Sciences, Rm 3040, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada R2H 2A6
* Corresponding author. Tel.: +1-204-237-2289; fax: +1-204-233-6723. E-mail address: peterz@sbrc.umanitoba.ca (P. Zahradka)
Objectives: Angiotensin II (AngII) generation in response to vascular injury has long been assumed to influence neointimal proliferation contributing to restenosis. This concept has been supported by evidence that ACE inhibition and AT1 receptor blockade effectively limits restenosis in the rat. On the other hand, ACE inhibition has proven ineffective in clinical trails. The present study examines the response of the porcine coronary artery after angioplasty in vitro and compares the actions of an ACE inhibitor to AngII receptor antagonists. Methods and results: Captopril, an ACE inhibitor, and the AngII receptor antagonists, losartan and PD123319, were evaluated for their ability to attenuate neointimal proliferation in a porcine organ culture model of coronary restenosis. The neointima was significantly increased by 300% after angioplasty compared to non-angioplasty controls. The AT1 receptor antagonist, losartan, produced a significant reduction in neointimal index at 10–5 mol/l, while its in vivo metabolite, EXP3174, reduced neointimal proliferation at 10–6 mol/l. PD123319, a selective antagonist of the AT2 receptor, also restricted neointimal proliferation at 10–5 mol/l. Treatment with captopril (10–6 mol/l) increased the neointimal proliferation by approximately 200% after angioplasty. Conclusions: Direct blockade of AngII receptors effectively inhibits cell proliferation and restenosis post-angioplasty in vitro. ACE inhibition, exclusive of flow, does not attenuate proliferative restenosis. These data suggest that AngII contributes to neointimal proliferation and validates the concept that receptor antagonists could contribute to the therapeutic management of restenosis.
KEYWORDS Restenosis; Angiotensin II; Angioplasty; Smooth muscle, porcine
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Lacchini, A. S. Heimann, F. S. Evangelista, L. Cardoso, G. J. J. Silva, and J. E. Krieger Cuff-induced vascular intima thickening is influenced by titration of the Ace gene in mice Physiol Genomics, May 13, 2009; 37(3): 225 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yau, P. Molnar, M. C. Moon, S. Buhay, J. P. Werner, K. Molnar, L. Saward, D. Del Rizzo, and P. Zahradka meta-Iodobenzylguanidine, an Inhibitor of Arginine-Dependent Mono(ADP-ribosyl)ation, Prevents Neointimal Hyperplasia J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 717 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schindler, A. Mueller, P. Bramlage, W. Boecking, W. Kirch, and J. Schweizer Comparison of Selective AT1-Receptor Blockade Versus ACE Inhibition for Restenosis Prophylaxis in Patients With Peripheral Occlusive Arterial Disease After Stent Angioplasty: A Randomized, Controlled, Proof-of-Concept Study Angiology, January 1, 2008; 58(6): 710 - 716. [Abstract] [PDF]
|
|
|
|
|
|
U. Yokoyama, Y. Sato, T. Akaike, S. Ishida, J. Sawada, T. Nagao, H. Quan, M. Jin, M. Iwamoto, S. Yokota, et al. Maternal vitamin A alters gene profiles and structural maturation of the rat ductus arteriosus Physiol Genomics, September 11, 2007; 31(1): 139 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zahradka, B. Wright, M. Fuerst, N. Yurkova, K. Molnar, and C. G. Taylor Peroxisome Proliferator-Activated Receptor {alpha} and {gamma} Ligands Differentially Affect Smooth Muscle Cell Proliferation and Migration J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 651 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Wolf, G. Sauter, H.-P. Rodemann, T. Risler, and B. R. Brehm Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism Nephrol. Dial. Transplant., February 1, 2005; 20(2): 312 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zahradka, G. Harding, B. Litchie, S. Thomas, J. P. Werner, D. P. Wilson, and N. Yurkova Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2861 - H2870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Schwartz, N. A. Chronos, and R. Virmani Preclinical restenosis models and drug-eluting stents: Still important, still much to learn J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1373 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yau, D. P. Wilson, J. P. Werner, and P. Zahradka Bradykinin receptor antagonists attenuate neointimal proliferation postangioplasty Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1648 - H1656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Del Rizzo, M. C. Moon, J. P. Werner, and P. Zahradka A novel organ culture method to study intimal hyperplasia at the site of a coronary artery bypass anastomosis Ann. Thorac. Surg., April 1, 2001; 71(4): 1273 - 1279. [Abstract] [Full Text] [PDF]
|
|